If approved, it would open the door to vaccinating children as young as 6 months old from COVID-19, potentially warding off highly contagious variants.
If approved, it would open the door to vaccinating children as young as 6 months old from COVID-19, potentially warding off highly contagious variants.
If approved, it would open the door to vaccinating children as young as 6 months old from COVID-19, potentially warding off highly contagious variants.
Moderna on Thursday asked the FDA to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening.